| Name | Title | Contact Details |
|---|
Alnylam is the world`s leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market. We are developing RNAi (RNA interference) as an innovative, entirely new class of medicines to treat rare genetic, cardio metabolic, acute hepatic infectious and central nervous system (CNS) and ocular diseases. Alnylam was founded in 2002 based on a Nobel Prize-winning breakthrough in biology – the discovery of RNAi, and a bold vision that this discovery could be used to silence disease-causing genes upstream of today`s medicines. We are relentless in our pursuit of new treatments because we believe that RNAi therapeutics can be used to treat many diseases for which treatment options do not exist or are inadequate. Overall, we believe that patients shouldn`t have to wait for hope. Alnylam is turning scientific possibility into reality - in 2018, the FDA and European EMA approved of our first product, ONPATTRO (patisiran) which is also the first-ever approved RNAi therapeutic. In 2019, the FDA approved our second product, GIVLAARI (givosiran). Our robust pipeline of investigational medicines includes multiple programs in late-stage and early-stage clinical development. We are a global and diverse company of more than 1,500 people. We pride ourself on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That`s why we`ve been named a Science Magazine Top Employer for two years in a row (`19-`20), a Boston Globe Top Place to Work 5x in a row (`15-`19) and one of Fast Company`s 50 Most Innovative Companies for 2019. We are based in Cambridge, U.S., with offices throughout Europe, Asia and South America.
Northern Light Health exists to make healthcare work for you. That is our mission. That is our purpose. Northern Light Health is the most expansive integrated health care system in Maine. We provide care to people from Portland to Presque Isle and from Blue Hill to Greenville. We are comprised of nine member hospitals with 584 long-term beds, a single physician-led medical group, eight nursing homes, five emergency transport members, 37 primary care locations, and we employ more than 12,000 people in Maine.
AMRA is the first in the world to transform images from a 6-minute whole body MRI scan into precise, 3D-volumetric, geographical fat and muscle measurements. Our aim is to redefine obesity and metabolic risk through precision medicine - understanding the interplay between fat, muscle and the development of metabolic disease.
Our mission at Aware Recovery Care is to help people affected by addiction “Recover Where You Live”. At Aware Recovery Care, we transform the home into a treatment center, delivering innovative addiction services to those in need, where they live. We treat addiction like a chronic illness, and our groundbreaking and evidence-based treatment approach provides comprehensive care from a multidisciplinary team of clinicians led by an Addiction Psychiatrist, a Family Systems Therapist, and a Registered Nurse. And with the help of a Certified Recovery Advisor, we help our clients learn new skills and daily habits required to maintain abstinence, while remaining amongst family and friends in their community, thereby avoiding the oftentimes difficult return home from traditional treatment options. Privacy and anonymity are respected, and dignity is preserved as we provide care that is discreet and effective. Authenticity, empathy, purpose, and thoughtfulness are at the heart of everything we do, and we seek deeply passionate people who are committed to immersing themselves in our mission. Those who are up for the task will be rewarded with rewarding mission-oriented workdays, and a voice at the table helping to build a transformational business entering a hypergrowth stage. Come join us as we create a preferred destination for top talent in the Healthcare community and set a new standard for the treatment of SUD. In early 2021, Aware received an investment by Health Enterprise Partners (HEP), a growth equity firm whose investors include some of the largest health systems and health insurance plans in the United States. Aware now operates in nine states (CT, MA, RI, NH, ME, VA, OH, IN, FL) and is poised for hyper-growth and national expansion in partnership with established national and regional payors, employers, and other stakeholders.
Diplomat Specialty Pharmacy is an independently held healthcare company dedicated to being a customer focused and innovative partner, providing medication management and clinical services in a caring, cost-effective, supportive environment, keeping patients healthier longer